Cazzato, R.L.; Hubelé, F.; De Marini, P.; Ouvrard, E.; Salvadori, J.; Addeo, P.; Garnon, J.; Kurtz, J.-E.; Greget, M.; Mertz, L.;
et al. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers 2021, 13, 6368.
https://doi.org/10.3390/cancers13246368
AMA Style
Cazzato RL, Hubelé F, De Marini P, Ouvrard E, Salvadori J, Addeo P, Garnon J, Kurtz J-E, Greget M, Mertz L,
et al. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers. 2021; 13(24):6368.
https://doi.org/10.3390/cancers13246368
Chicago/Turabian Style
Cazzato, Roberto Luigi, Fabrice Hubelé, Pierre De Marini, Eric Ouvrard, Julien Salvadori, Pietro Addeo, Julien Garnon, Jean-Emmanuel Kurtz, Michel Greget, Luc Mertz,
and et al. 2021. "Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures" Cancers 13, no. 24: 6368.
https://doi.org/10.3390/cancers13246368
APA Style
Cazzato, R. L., Hubelé, F., De Marini, P., Ouvrard, E., Salvadori, J., Addeo, P., Garnon, J., Kurtz, J.-E., Greget, M., Mertz, L., Goichot, B., Gangi, A., & Imperiale, A.
(2021). Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers, 13(24), 6368.
https://doi.org/10.3390/cancers13246368